PHYSICIANS: Check To Make Sure The FDA Approved Your Test Kit For Home Use

Why This Topic Matters

Understanding the article helps readers avoid denials, confirm that the testing setup matches coverage requirements, and support appropriate documentation for repeat testing and diabetes-related claims.

Article Sections

1. Coverage and coding considerations for A1C testing

   This section discusses billing and coverage issues surrounding hemoglobin A1C testing in office-based settings. It focuses on how the service is distinguished by testing environment, device type, and payer expectations.

2. Device approval, CLIA, and claim support

   This section addresses device approval status, laboratory certification, and documentation support for submitted claims. It also touches on carrier review and proof of kit selection.

3. Clinical context and testing frequency

   This section provides background on diabetes monitoring and the role of A1C in tracking glycemic control. It also summarizes general frequency considerations and the need for documentation when testing is repeated more often.